These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171 [TBL] [Abstract][Full Text] [Related]
10. The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo. Dana N; Haghjooy Javanmard S; Vaseghi G Clin Transl Oncol; 2020 Apr; 22(4):486-494. PubMed ID: 31175545 [TBL] [Abstract][Full Text] [Related]
11. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667 [TBL] [Abstract][Full Text] [Related]
14. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation. Derkow K; Krüger C; Dembny P; Lehnardt S PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016 [TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Ye P; Fang H; Zhou X; He YL; Liu YX Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179 [TBL] [Abstract][Full Text] [Related]
16. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. Koufany M; Jouzeau JY; Moulin D Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921 [TBL] [Abstract][Full Text] [Related]
17. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells. Ji Y; Wang Z; Li Z; Liu J Cell Physiol Biochem; 2010; 25(6):631-40. PubMed ID: 20511708 [TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate. Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225 [TBL] [Abstract][Full Text] [Related]
19. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169 [TBL] [Abstract][Full Text] [Related]
20. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway. Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]